Back
Livento Group, Inc. Vs. MiNK Therapeutics, Inc. Sector Stock Comparison
Sell
27
NUGN
Livento Group, Inc.
Last Price:
$0.0000
Seasonality Move:
0.6%
Sell
34
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.71
Seasonality Move:
-18.07%
Sell
27
Livento Group, Inc. (NUGN)
is a Sell
Is Livento Group, Inc. a Buy, Sell or Hold?
-
The current Livento Group, Inc. [NUGN] share price is $0.0025. The Score for NUGN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
NUGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.96. The Score for INKT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NUGN Stock Price Chart
What is Livento Group, Inc.'s stock price today?
-
The Livento Group, Inc. share price today is $0.0025Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.96Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight selling pressure.
NUGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 41.74 | Sell |
| Chaikin Money Flow: | 36000 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 47.65 | Sell |
| Chaikin Money Flow: | -11714 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.88 - 12.8) | Buy |
| Bollinger Bands (100): | (12.31 - 15.41) | Sell |
NUGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0 | Sell |
| 20-day SMA: | 0 | Sell |
| 50-day SMA: | 0 | Sell |
| 200-day SMA: | 7.7 | Sell |
| 8-day EMA: | 0 | Sell |
| 20-day EMA: | 0 | Buy |
| 50-day EMA: | 0.1 | Sell |
| 200-day EMA: | 23.57 | Sell |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.29 | Sell |
| 20-day SMA: | 11.54 | Buy |
| 50-day SMA: | 12.98 | Sell |
| 200-day SMA: | 11.84 | Buy |
| 8-day EMA: | 12.15 | Sell |
| 20-day EMA: | 12.09 | Sell |
| 50-day EMA: | 12.72 | Sell |
| 200-day EMA: | 12.23 | Sell |
Livento Group, Inc. Earnings Growth & NUGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Livento Group, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||